Metraipolis › archive › dc_4891c3719fec
Safety and efficacy of SGLT2i administration in dilated cardiomyopathy: protocol for a systematic review and meta-analysis — Europe PMC PMID:41019438
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41019438
- DOI
- 10.3389/fcvm.2025.1575493
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T23:53:26.909Z
- SHA-256 of the archived text
0b00fe2fc5446e327d2b0bf30570b885c19f86c51639bcc07574714a832b9935- Stable URL of this page
https://metraipolis.com/documento/dc_4891c3719fec
How to cite
Safety and efficacy of SGLT2i administration in dilated cardiomyopathy: protocol for a systematic review and meta-analysis — Europe PMC PMID:41019438 — Europe PMC (en), https://europepmc.org/article/MED/41019438 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4891c3719fec (Metraipolis archive dc_4891c3719fec, sha256 0b00fe2fc5446e327d2b0bf30570b885c19f86c51639bcc07574714a832b9935)
BibTeX
@misc{dc4891c3719fec,
title = {Safety and efficacy of SGLT2i administration in dilated cardiomyopathy: protocol for a systematic review and meta-analysis — Europe PMC PMID:41019438},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41019438},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4891c3719fec; sha256 0b00fe2fc5446e327d2b0bf30570b885c19f86c51639bcc07574714a832b9935},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019438. Agents can read the archived copy with the MCP tool read_document.